These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 11895916)

  • 21. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma.
    Hu N; Flaig MJ; Su H; Shou JZ; Roth MJ; Li WJ; Wang C; Goldstein AM; Li G; Emmert-Buck MR; Taylor PR
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6013-22. PubMed ID: 15447985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells.
    Marreiros A; Dudgeon K; Dao V; Grimm MO; Czolij R; Crossley M; Jackson P
    Oncogene; 2005 Jan; 24(4):637-49. PubMed ID: 15580298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade.
    Bouras T; Frauman AG
    J Pathol; 1999 Aug; 188(4):382-8. PubMed ID: 10440748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of KAI1/CD82 expression in bone and soft tissue tumors is not associated with lung metastasis.
    Arihiro K; Inai K
    Pathol Res Pract; 2001; 197(9):627-33. PubMed ID: 11569927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear factor-kappaB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53.
    Shinohara T; Miki T; Nishimura N; Nokihara H; Hamada H; Mukaida N; Sone S
    Cancer Res; 2001 Jan; 61(2):673-8. PubMed ID: 11212267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancer.
    Ow K; Delprado W; Fisher R; Barrett J; Yu Y; Jackson P; Russell PJ
    J Pathol; 2000 May; 191(1):39-47. PubMed ID: 10767717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of epigenetic inactivation of the human four and a half LIM domains 1 gene in human oral cancer.
    Koike K; Kasamatsu A; Iyoda M; Saito Y; Kouzu Y; Koike H; Sakamoto Y; Ogawara K; Tanzawa H; Uzawa K
    Int J Oncol; 2013 Jan; 42(1):141-50. PubMed ID: 23123766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
    Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
    Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of metastasis suppressor gene (KAI1/CD82) in oral squamous cell carcinoma and its clinico-pathological significance.
    Imai Y; Sasaki T; Shinagawa Y; Akimoto K; Fujibayashi T
    Oral Oncol; 2002 Sep; 38(6):557-61. PubMed ID: 12167433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival.
    Farhadieh RD; Smee R; Ow K; Yang JL; Russell PJ; Crouch R; Jackson P; Jacobson IV
    Cancer Lett; 2004 Sep; 213(1):91-8. PubMed ID: 15312688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KAI1 protein is down-regulated during the progression of human breast cancer.
    Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M
    Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTEN expression and methylation status in oral squamous cell carcinoma.
    Kurasawa Y; Shiiba M; Nakamura M; Fushimi K; Ishigami T; Bukawa H; Yokoe H; Uzawa K; Tanzawa H
    Oncol Rep; 2008 Jun; 19(6):1429-34. PubMed ID: 18497947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma.
    Guo C; Liu QG; Zhang L; Song T; Yang X
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):389-96. PubMed ID: 19666408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the ANA gene as a candidate for the chromosome 21q oral cancer susceptibility locus.
    Yamamoto N; Uzawa K; Yakushiji T; Shibahara T; Noma H; Tanzawa H
    Br J Cancer; 2001 Mar; 84(6):754-9. PubMed ID: 11259088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KAI1 expression in thyroid neoplasms: its linkage with clinicopathologic features in papillary carcinoma.
    Ito Y; Yoshida H; Uruno T; Nakano K; Takamura Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Kuma K; Miyauchi A
    Pathol Res Pract; 2003; 199(2):79-83. PubMed ID: 12747469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Network-based analysis of calcium-binding protein genes identifies Grp94 as a target in human oral carcinogenesis.
    Nomura H; Uzawa K; Yamano Y; Fushimi K; Ishigami T; Kato Y; Saito K; Nakashima D; Higo M; Kouzu Y; Ono K; Ogawara K; Shiiba M; Bukawa H; Yokoe H; Tanzawa H
    Br J Cancer; 2007 Sep; 97(6):792-801. PubMed ID: 17726464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of maspin expression is associated with development and progression of gastric carcinoma with p53 abnormality.
    Ito R; Nakayama H; Yoshida K; Oda N; Yasui W
    Oncol Rep; 2004 Nov; 12(5):985-90. PubMed ID: 15492782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
    Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
    Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.